Source link : https://www.newshealth.biz/health-news/fda-investigating-blood-cancer-risk-with-gene-therapy-skysona/
The FDA said on Wednesday that it is investigating reports of blood cancers — including life-threatening cases of myelodysplastic syndrome and acute myeloid leukemia — in patients with early, active cerebral adrenoleukodystrophy (CALD) who were treated with elivaldogene autotemcel (eli-cel; Skysona). The reported cases came from clinical trials. Cancer diagnoses were 14 to 92 months […]
Author : News Health
Publish date : 2024-11-27 20:07:38
Copyright for syndicated content belongs to the linked Source.